Commodore Capital LP Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$473.0B
Holdings
24
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 2,615,762 | $59.2B | 12.52% | |
| 2 | XENEXENON PHARMACEUTICALS INC | 1,594,932 | $48.5B | 10.26% | |
| 3 | COGTCOGENT BIOSCIENCES INC | 4,944,708 | $44.6B | 9.43% | |
| 4 | BLUBELLUS HEALTH INC NEW | 4,479,784 | $41.4B | 8.75% | |
| 5 | CYTKCYTOKINETICS INC | 893,646 | $35.1B | 7.42% | |
| 6 | ACRSACLARIS THERAPEUTICS INC | 2,410,622 | $33.7B | 7.11% | |
| 7 | KURAKURA ONCOLOGY INC | 1,826,491 | $33.5B | 7.08% | |
| 8 | OPHTEURIVERIC BIO INC | 2,409,961 | $23.2B | 4.90% | |
| 9 | 1T7TRICIDA INC | 2,028,453 | $19.6B | 4.15% | |
| 10 | VRDNVIRIDIAN THERAPEUTICS INC | 1,638,609 | $19.0B | 4.01% | |
| 11 | CBAYUSDCYMABAY THERAPEUTICS INC | 5,738,500 | $16.9B | 3.58% | |
| 12 | —SATSUMA PHARMACEUTICALS INC | 3,711,286 | $15.4B | 3.25% | |
| 13 | TCE2CELLDEX THERAPEUTICS INC NEW | 538,812 | $14.5B | 3.07% | |
| 14 | DAWNDAY ONE BIOPHARMACEUTICALS I | 739,661 | $13.2B | 2.80% | |
| 15 | VTGNUSDVISTAGEN THERAPEUTICS INC | 13,049,079 | $11.5B | 2.43% | |
| 16 | ARWRARROWHEAD PHARMACEUTICALS IN | 312,533 | $11.0B | 2.33% | |
| 17 | KPTIEURKARYOPHARM THERAPEUTICS INC | 1,935,609 | $8.7B | 1.85% | |
| 18 | CELCCELCUITY INC | 920,464 | $8.4B | 1.77% | |
| 19 | RZLTREZOLUTE INC | 1,210,000 | $3.9B | 0.83% | |
| 20 | IMUXIMMUNIC INC | 893,013 | $3.1B | 0.66% | |
| 21 | KALVKALVISTA PHARMACEUTICALS INC | 312,553 | $3.1B | 0.65% | |
| 22 | —BCLS ACQUISITION CORP | 250,000 | $2.5B | 0.52% | |
| 23 | TNYATENAYA THERAPEUTICS INC | 357,699 | $2.0B | 0.43% | |
| 24 | IVAINVENTIVA SA | 175,500 | $995.0M | 0.21% |